EP 1343819 A4 20050323 - HLA-A2.1 BINDING PEPTIDES AND THEIR USES
Title (en)
HLA-A2.1 BINDING PEPTIDES AND THEIR USES
Title (de)
HLA-A2.1- BINDUNGSPEPTIDE UND IHRE VERWENDUNG
Title (fr)
PEPTIDES DE FIXATION DE HLA-A2.1 ET LEURS UTILISATIONS
Publication
Application
Priority
US 0024102 W 20000901
Abstract (en)
[origin: WO0220616A1] The present invention provides the means and methods for selecting immunogenic peptides and the immunogenic peptide compositions capable of specifically binding glycoproteins encoded HLA-A2.1 allele and inducing T cell activation in T cells restricted by the A2.1 allele. The peptides are useful to elicit an immune response against a desired antigen.
IPC 1-7
C07K 16/00; C07H 21/04; A61K 39/00; C07K 14/02; C07K 14/03; C07K 14/08; C07K 14/11; C07K 14/16; C07K 14/18; C12N 9/90
IPC 8 full level
C12N 15/09 (2006.01); A61K 39/00 (2006.01); A61K 39/21 (2006.01); A61K 39/29 (2006.01); A61P 1/16 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01); C07K 7/04 (2006.01); C07K 14/02 (2006.01); C07K 14/03 (2006.01); C07K 14/08 (2006.01); C07K 14/11 (2006.01); C07K 14/16 (2006.01); C07K 14/18 (2006.01); C12N 9/90 (2006.01)
CPC (source: EP US)
A61K 39/0011 (2013.01 - EP US); A61K 39/001106 (2018.08 - EP US); A61K 39/001151 (2018.08 - EP US); A61K 39/001186 (2018.08 - EP US); A61P 1/16 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 31/18 (2018.01 - EP); A61P 35/00 (2018.01 - EP); C07K 14/005 (2013.01 - EP); C12N 9/90 (2013.01 - EP); A61K 2039/57 (2013.01 - EP); C12N 2730/10122 (2013.01 - EP); C12N 2740/16222 (2013.01 - EP); C12N 2760/16122 (2013.01 - EP); C12N 2770/24222 (2013.01 - EP)
Citation (search report)
- [X] WO 9833888 A1 19980806 - EPIMMUNE INC [US]
- [X] WO 9741440 A1 19971106 - UNIV LEIDEN [NL], et al
- [E] WO 0142270 A1 20010614 - EPIMMUNE INC [US], et al
- [E] WO 0141741 A1 20010614 - EPIMMUNE INC [US], et al
- [E] WO 0136452 A2 20010525 - EPIMMUNE INC [US], et al
- [X] WIZEL BENJAMIN ET AL: "Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses", JOURNAL OF CLINICAL INVESTIGATION, vol. 102, no. 5, 1 September 1998 (1998-09-01), pages 1062 - 1071, XP002285521, ISSN: 0021-9738
- [DX] FALK K ET AL: "ALLELE-SPECIFIC MOTIFS REVEALED BY SEQUENCING OF SELF-PEPTIDES ELUTED FROM MHC MOLECULES", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 351, no. 6324, 23 May 1991 (1991-05-23), pages 290 - 296, XP000310533, ISSN: 0028-0836
- [X] KAWASHIMA I ET AL: "THE MULTI-EPITOPE APPROACH FOR IMMUNOTHERAPY FOR CANCER: IDENTIFICATION OF SEVERAL CTL EPITOPES FROM VARIOUS TUMOR-ASSOCIATED ANTIGENS EXPRESSED ON SOLID EPITHELIAL TUMORS", HUMAN IMMUNOLOGY, NEW YORK, NY, US, vol. 59, no. 1, January 1998 (1998-01-01), pages 1 - 14, XP001012509, ISSN: 0198-8859
- [X] ALTERS S E ET AL: "DENDRITIC CELLS PULSED WITH CEA PEPTIDE INDUCE CEA-SPECIFIC CTL WITH RESTRICTED TCR REPERTOIRE", JOURNAL OF IMMUNOTHERAPY, RAVEN PRESS, NEW YORK, US, vol. 21, no. 1, January 1998 (1998-01-01), pages 17 - 26, XP001061479, ISSN: 1524-9557
- See also references of WO 0220616A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0220616 A1 20020314; AU 7574800 A 20020322; CA 2420225 A1 20020314; EP 1343819 A1 20030917; EP 1343819 A4 20050323; EP 1619207 A2 20060125; EP 1619207 A3 20060208; JP 2004517609 A 20040617
DOCDB simple family (application)
US 0024102 W 20000901; AU 7574800 A 20000901; CA 2420225 A 20000901; EP 00964938 A 20000901; EP 05016493 A 20000901; JP 2002525235 A 20000901